{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:43:12Z","timestamp":1777610592601,"version":"3.51.4"},"reference-count":229,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.drudis.2019.11.016","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T09:27:08Z","timestamp":1576142828000},"page":"380-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cell-based immunomodulatory therapy approaches for type 1 diabetes mellitus"],"prefix":"10.1016","volume":"25","author":[{"given":"Labe","family":"Black","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4463-3550","authenticated-orcid":false,"given":"Tatiana","family":"Zorina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2019.11.016_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1634\/stemcells.21-4-377","article-title":"Recovery of the endogenous \u03b2 cell function in the NOD model of autoimmune diabetes","volume":"21","author":"Zorina","year":"2003","journal-title":"Stem Cells"},{"key":"10.1016\/j.drudis.2019.11.016_bib0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/cmi.2012.36","article-title":"Treg cells in pancreatic lymph nodes: the possible role in diabetogenesis and \u03b2 cell regeneration in a T1D model","volume":"9","author":"Nti","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0015","first-page":"1101","article-title":"Graft-versus-host disease-free, and relapse-free survival in Japanese patients with hematological malignancies","volume":"59","author":"Inamoto","year":"2018","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.drudis.2019.11.016_bib0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/CCO.0000000000000488","article-title":"Myelodysplastic syndromes in children","volume":"30","author":"Galaverna","year":"2018","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0025","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V99.5.1840","article-title":"A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation","volume":"99","author":"Kean","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0030","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/pbc.24177","article-title":"Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease","volume":"59","author":"Locatelli","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.drudis.2019.11.016_bib0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12185-011-0931-7","article-title":"Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria","volume":"94","author":"Taniguchi","year":"2011","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1517\/14712598.2011.540235","article-title":"Stem cell-based strategies for the treatment of type 1 diabetes mellitus","volume":"11","author":"Wen","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.drudis.2019.11.016_bib0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaut.2007.12.011","article-title":"A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases","volume":"30","author":"Ikehara","year":"2008","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.drudis.2019.11.016_bib0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12185-017-2217-1","article-title":"Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia","volume":"106","author":"Wu","year":"2017","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0055","doi-asserted-by":"crossref","first-page":"954","DOI":"10.7326\/0003-4819-114-11-954","article-title":"Immunologic tolerance to renal allografts after bone marrow transplants from the same donors","volume":"114","author":"Sayegh","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0060","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015529","article-title":"Induction of tolerance through mixed chimerism","volume":"4","author":"Sachs","year":"2014","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0065","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/sctm.16-0358","article-title":"Mechanisms of tolerance induction by hematopoietic chimerism: the immune perspective","volume":"6","author":"Yolcu","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/19381956.2015.1130780","article-title":"Facilitating cells: translation of hematopoietic chimerism to achieve clinical tolerance","volume":"6","author":"Ildstad","year":"2015","journal-title":"Chimerism"},{"key":"10.1016\/j.drudis.2019.11.016_bib0075","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0140-6736(94)91881-3","article-title":"Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor","volume":"343","author":"Jacobsen","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2019.11.016_bib0080","first-page":"802","article-title":"Marrow transfusions increase pluripotential stem cells in normal hosts","volume":"13","author":"Cronkite","year":"1985","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0085","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.exphem.2016.04.016","article-title":"To condition or not to condition-that is the question: the evolution of nonmyeloablative conditions for transplantation","volume":"44","author":"Migliaccio","year":"2016","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0090","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1182\/blood.V84.8.2436.2436","article-title":"Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells","volume":"84","author":"Kaufman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0095","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/ajt.13511","article-title":"Characterization of human CD8(1)TCR(-) facilitating cells in vitro and in vivo in a NOD\/SCID\/IL2rgamma(null) mouse model","volume":"16","author":"Huang","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.drudis.2019.11.016_bib0100","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","article-title":"Osteoblastic cells regulate the haematopoietic stem cell niche","volume":"425","author":"Calvi","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nature11926","article-title":"CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance","volume":"495","author":"Greenbaum","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib0110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature17624","article-title":"Distinct bone marrow blood vessels differentially regulate haematopoiesis","volume":"532","author":"Itkin","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature15250","article-title":"Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal","volume":"526","author":"Acar","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib0120","first-page":"19","article-title":"Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo","volume":"25","author":"Friedenstein","year":"1980","journal-title":"Haematol. Blood Transfus."},{"key":"10.1016\/j.drudis.2019.11.016_bib0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00007890-197404000-00001","article-title":"Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo","volume":"17","author":"Friedenstein","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.drudis.2019.11.016_bib0130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2017-02-735290","article-title":"Genetic predisposition to hematologic malignancies: management and surveillance","volume":"130","author":"Godley","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1947601911408076","article-title":"Genetic abnormalities and challenges in the treatment of acute myeloid leukemia","volume":"2","author":"Kumar","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.drudis.2019.11.016_bib0140","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/742976","article-title":"It is all in the blood: the multifaceted contribution of circulating progenitor cells in diabetic complications","volume":"2012","author":"Fadini","year":"2012","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.drudis.2019.11.016_bib0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11892-016-0730-x","article-title":"Bone marrow-derived stem cells: a mixed blessing in the multifaceted world of diabetic complications","volume":"16","author":"Mangialardi","year":"2016","journal-title":"Curr. Diab Rep."},{"key":"10.1016\/j.drudis.2019.11.016_bib0150","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood-2008-10-183459","article-title":"Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation","volume":"114","author":"Dominici","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0155","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1359\/JBMR.050514","article-title":"Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone","volume":"20","author":"Kume","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.drudis.2019.11.016_bib0160","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1182\/blood-2007-10-115725","article-title":"Donor cell-derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation","volume":"111","author":"Dominici","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0165","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/CIRCRESAHA.112.300598","article-title":"Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155\/FOXO3a signaling pathway","volume":"112","author":"Spinetti","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.drudis.2019.11.016_bib0170","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1084\/jem.20090889","article-title":"Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock","volume":"206","author":"Busik","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0175","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.febslet.2014.02.030","article-title":"Hyperglycemia induces abnormal gene expression in hematopoietic stem cells and their progeny in diabetic neuropathy","volume":"588","author":"Katagi","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drudis.2019.11.016_bib0180","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00125-015-3735-0","article-title":"Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes","volume":"58","author":"Dang","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.drudis.2019.11.016_bib0185","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1089\/scd.2017.0025","article-title":"Intrinsic mesenchymal stem cell dysfunction in diabetes mellitus: implications for autologous cell therapy","volume":"26","author":"van de Vyver","year":"2017","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.drudis.2019.11.016_bib0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bcmd.2013.05.002","article-title":"Diabetes impairs mobilization of mouse bone marrow-derived Lin(-)\/VEGF-R2(1) progenitor cells","volume":"51","author":"Barthelmes","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.drudis.2019.11.016_bib0195","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000281826","article-title":"Diabetes induced changes in rat mesenchymal stem cells","volume":"191","author":"Stolzing","year":"2010","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.drudis.2019.11.016_bib0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.vph.2013.01.003","article-title":"Restoring stem cell mobilization to promote vascular repair in diabetes","volume":"58","author":"Albiero","year":"2013","journal-title":"Vascul Pharmacol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0205","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002191","article-title":"Diabetes impairs hematopoietic stem cell mobilization by altering niche function","volume":"3","author":"Ferraro","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13287-016-0351-y","article-title":"Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients","volume":"7","author":"de Lima","year":"2016","journal-title":"Stem Cell. Res. Ther."},{"key":"10.1016\/j.drudis.2019.11.016_bib0215","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00125-012-2588-z","article-title":"Reducing lower leg amputations in diabetes: a challenge for patients, healthcare providers and the healthcare system","volume":"55","author":"Schaper","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.drudis.2019.11.016_bib0220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.yexmp.2018.01.003","article-title":"Functionally compromised synovium-derived mesenchymal stem cells in Charcot neuroarthropathy","volume":"104","author":"Mitchell","year":"2018","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0225","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.2337\/db13-1366","article-title":"Diabetes irreversibly depletes bone marrow-derived mesenchymal progenitor cell subpopulations","volume":"63","author":"Januszyk","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2019.11.016_bib0230","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12967-014-0337-4","article-title":"Disturbed angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery disease and diabetes mellitus type 2","volume":"12","author":"Dzhoyashvili","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0235","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.3727\/096368914X682792","article-title":"Diabetic mesenchymal stem cells are ineffective for improving limb ischemia due to their impaired angiogenic capability","volume":"24","author":"Kim","year":"2015","journal-title":"Cell Transplant."},{"key":"10.1016\/j.drudis.2019.11.016_bib0240","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1089\/scd.2018.0219","article-title":"Compromised antibacterial function of multipotent stromal cells in diabetes","volume":"28","author":"Cho","year":"2019","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.drudis.2019.11.016_bib0245","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/9780470697405.ch14","article-title":"Towards a curative therapy in type 1 diabetes: remission of autoimmunity, maintenance and augmentation of beta cell mass","volume":"292","author":"Waldron-Lynch","year":"2008","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.drudis.2019.11.016_bib0250","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(09)60568-7","article-title":"Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study","volume":"373","author":"Patterson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2019.11.016_bib0255","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0889-8529(01)00017-2","article-title":"Type 1A diabetes mellitus-associated autoimmunity","volume":"31","author":"Liu","year":"2002","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.drudis.2019.11.016_bib0260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/014572179702300107","article-title":"The relationship between nonroutine use of insulin, food, and exercise and the occurrence of hypoglycemia in adults with IDDM and varying degrees of hypoglycemic awareness and metabolic control","volume":"23","author":"Clarke","year":"1997","journal-title":"Diabetes Educ."},{"key":"10.1016\/j.drudis.2019.11.016_bib0265","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.2174\/1381612811319130015","article-title":"Mesenchymal stem\/stromal cells: a new \u201ccells as drugs\u2019\u2019 paradigm. Efficacy and critical aspects in cell therapy","volume":"19","author":"de Girolamo","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drudis.2019.11.016_bib0270","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13075-015-0819-7","article-title":"Update on mesenchymal stem cell-based therapy in lupus and scleroderma","volume":"17","author":"Cras","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.drudis.2019.11.016_bib0275","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12016-016-8552-9","article-title":"Adipose-derived mesenchymal stem cells in autoimmune disorders: state of the art and perspectives for systemic sclerosis","volume":"52","author":"Maria","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0280","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clim.2013.01.009","article-title":"Hematopoetic and mesenchymal stem cell transplantation in the treatment of refractory systemic lupus erythematosus\u2014where are we now?","volume":"148","author":"Collins","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0285","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1042\/CS20171251","article-title":"Mesenchymal stromal cells improve human islet function through released products and extracellular matrix","volume":"131","author":"Arzouni","year":"2017","journal-title":"Clin. Sci."},{"key":"10.1016\/j.drudis.2019.11.016_bib0290","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nbt841","article-title":"Bone marrow-derived stem cells initiate pancreatic regeneration","volume":"21","author":"Hess","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0295","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2337\/diabetes.53.1.91","article-title":"Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury","volume":"53","author":"Mathews","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2019.11.016_bib0300","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003835","article-title":"Mixed chimerism and growth factors augment beta cell regeneration and reverse late-stage type 1 diabetes","volume":"4","author":"Wang","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0305","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.dsx.2018.06.021","article-title":"Current status of stem cell therapy, scaffolds for the treatment of diabetes mellitus","volume":"12","author":"Gharravi","year":"2018","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.drudis.2019.11.016_bib0310","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.numecd.2017.02.004","article-title":"Stem cells to restore insulin production and cure diabetes","volume":"27","author":"Sordi","year":"2017","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.drudis.2019.11.016_bib0315","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jcyt.2016.06.006","article-title":"Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus","volume":"18","author":"Vanikar","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.drudis.2019.11.016_bib0320","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00441-016-2499-2","article-title":"Mesenchymal stem cells moderate immune response of type 1 diabetes","volume":"368","author":"Xv","year":"2017","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.drudis.2019.11.016_bib0325","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02256058","article-title":"Characterization and functionality of cell surface molecules on human mesenchymal stem cells","volume":"10","author":"Majumdar","year":"2003","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.drudis.2019.11.016_bib0330","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0301-472X(03)00110-3","article-title":"HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells","volume":"31","author":"Le Blanc","year":"2003","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.trre.2012.11.003","article-title":"Potential role of mesenchymal stromal cells in pancreatic islet transplantation","volume":"27","author":"Hematti","year":"2013","journal-title":"Transplant. Rev."},{"key":"10.1016\/j.drudis.2019.11.016_bib0340","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3892\/ijmm.2013.1572","article-title":"Immunological characteristics of human umbilical cord mesenchymal stem cells and the therapeutic effects of their transplantation on hyperglycemia in diabetic rats","volume":"33","author":"Wang","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0345","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2337\/db08-0180","article-title":"Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes","volume":"57","author":"Abdi","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2019.11.016_bib0350","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1210\/er.2011-0008","article-title":"Immunological applications of stem cells in type 1 diabetes","volume":"32","author":"Fiorina","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.drudis.2019.11.016_bib0355","doi-asserted-by":"crossref","first-page":"e0186637","DOI":"10.1371\/journal.pone.0186637","article-title":"Intrapancreatic injection of human bone marrow-derived mesenchymal stem\/stromal cells alleviates hyperglycemia and modulates the macrophage state in streptozotocin-induced type 1 diabetic mice","volume":"12","author":"Murai","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2019.11.016_bib0360","first-page":"477","article-title":"Vildagliptin enhances differentiation of insulin producing cells from adipose-derived mesenchymal stem cells","volume":"20","author":"Karimi","year":"2019","journal-title":"Cell. J."},{"key":"10.1016\/j.drudis.2019.11.016_bib0365","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2019.11.016_bib0370","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/5584_2018_305","article-title":"Human induced pluripotent stem cells in the curative treatment of diabetes and potential impediments ahead","volume":"1144","author":"Dadheech","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0375","doi-asserted-by":"crossref","first-page":"15768","DOI":"10.1073\/pnas.0906894106","article-title":"Generation of pluripotent stem cells from patients with type 1 diabetes","volume":"106","author":"Maehr","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2019.11.016_bib0380","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2019.11.016_bib0385","doi-asserted-by":"crossref","first-page":"17326","DOI":"10.1002\/jcp.28352","article-title":"Generation of insulin-producing hepatocyte-like cells from human Wharton\u2019s jelly mesenchymal stem cells as an alternative source of islet cells","volume":"234","author":"Beikmohammadi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0390","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13770-018-0143-9","article-title":"Current status of stem cell treatment for type I diabetes mellitus","volume":"15","author":"Kakkar","year":"2018","journal-title":"Tissue Eng. Regen. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0395","unstructured":"Stem cell therapy for type 1 diabetes mellitus."},{"key":"10.1016\/j.drudis.2019.11.016_bib0400","unstructured":"Stem cell therapy for type 2 diabetes mellitus."},{"key":"10.1016\/j.drudis.2019.11.016_bib0405","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4103\/2230-8210.140257","article-title":"Efficacy and safety of autologous bone marrow derived hematopoietic stem cell transplantation in patients with type 2 DM: A 15 months follow-up study","volume":"18","author":"Bhansali","year":"2014","journal-title":"Indian. J. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2019.11.016_bib0410","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/scd.2016.0275","article-title":"Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus","volume":"26","author":"Bhansali","year":"2009","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.drudis.2019.11.016_bib0415","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13098-017-0248-7","article-title":"Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on beta-cell function and insulin sensitivity","volume":"9","author":"Bhansali","year":"2017","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.drudis.2019.11.016_bib0420","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/scd.2016.0275","article-title":"Efficacy of autologous bone marrow-derived mesenchymal stem cell and mononuclear cell transplantation in type 2 diabetes mellitus: a randomized, placebo-controlled comparative study","volume":"26","author":"Bhansali","year":"2017","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.drudis.2019.11.016_bib0425","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sctm.17-0139","article-title":"Autologous mesenchymal stem cell and islet cotransplantation: safety and efficacy","volume":"7","author":"Wang","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0430","first-page":"82","article-title":"A review of clinical trials: mesenchymal stem cell transplant therapy in type 1 and type 2 diabetes mellitus","volume":"7","author":"Cho","year":"2018","journal-title":"Am. J. Stem Cells"},{"key":"10.1016\/j.drudis.2019.11.016_bib0435","series-title":"Mixed allogeneic chimerism for the prevention of autoimmune diabetes, and the reversal of insulitis in the non-obese diabetic (NOD) mouse. 150","author":"Zorina","year":"1993"},{"key":"10.1016\/j.drudis.2019.11.016_bib0440","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.5966\/sctm.2015-0272","article-title":"Type 1 diabetes mellitus donor mesenchymal stromal cells exhibit comparable potency to healthy controls in vitro","volume":"5","author":"Davies","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0445","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1634\/stemcells.2007-0226","article-title":"Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis","volume":"25","author":"Wu","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.drudis.2019.11.016_bib0450","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2230.2011.04304.x","article-title":"Role of autologous mesenchymal stem cells associated with platelet-rich plasma on healing of cutaneous wounds in diabetic mice","volume":"37","author":"Argolo Neto","year":"2012","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0455","first-page":"219","article-title":"Autologous bone marrow-derived stem cells for chronic wounds of the lower extremity: a retrospective study","volume":"22","author":"Mulder","year":"2010","journal-title":"Wounds"},{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2019.11.016_bib0460","doi-asserted-by":"crossref","first-page":"236","DOI":"10.6002\/ect.MESOT2018.P100","article-title":"Autologous mesenchymal stem cell transplant in patients with type 1 diabetes mellitus","volume":"17","author":"Ulyanova","year":"2019","journal-title":"Exp. Clin. Transplant."},{"key":"10.1016\/j.drudis.2019.11.016_bib0465","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/bjh.13504","article-title":"Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia","volume":"170","author":"Mantelli","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0470","article-title":"Idiopathic thrombocytopenic purpura (ITP) - new era for an old disease","author":"Onisai","year":"2019","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0475","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s12185-016-2129-5","article-title":"Primary autoimmune myelofibrosis: a case report and review of the literature","volume":"105","author":"Abaza","year":"2017","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0480","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/cncr.24984","article-title":"Cause of death in patients with lower-risk myelodysplastic syndrome","volume":"116","author":"Dayyani","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.drudis.2019.11.016_bib0485","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005792-197605000-00005","article-title":"Causes of death in adults with acute leukemia","volume":"55","author":"Chang","year":"1976","journal-title":"Medicine"},{"key":"10.1016\/j.drudis.2019.11.016_bib0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006505","article-title":"HIV-1 infection depletes human CD341CD38- hematopoietic progenitor cells via pDC-dependent mechanisms","volume":"13","author":"Li","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.drudis.2019.11.016_bib0495","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13010038","article-title":"Profile of HIV-infected Hispanics with pancytopenia","volume":"13","author":"Santiago-Rodriguez","year":"2015","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"10.1016\/j.drudis.2019.11.016_bib0500","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cbi.2010.03.049","article-title":"Immunosuppressive therapy of cyclosporin A for severe benzene-induced haematopoietic disorders and a 6-month follow-up","volume":"186","author":"Song","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.drudis.2019.11.016_bib0505","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1084\/jem.37.3.319","article-title":"Studies on the changes produced by roentgen rays in inflamed connective tissue","volume":"37","author":"Maximow","year":"1923","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0510","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1084\/jem.35.2.187","article-title":"Roentgen ray intoxication: I. unit dose over thorax negative-over abdomen lethal. epithelium of small intestine sensitive to X-rays","volume":"35","author":"Warren","year":"1922","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0515","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1084\/jem.35.2.203","article-title":"Roentgen ray intoxication: Ii. a study of the sequence of clinical, anatomical, and histological changes following a unit dose of X-rays","volume":"35","author":"Warren","year":"1922","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0520","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1084\/jem.35.2.213","article-title":"Roentgen ray intoxication: Iii. speed of autolysis of various body tissues after lethal X-ray exposures. the remarkable disturbance in the epithelium of the small intestine","volume":"35","author":"Warren","year":"1922","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0525","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1073\/pnas.1801480116","article-title":"Clonal-level lineage commitment pathways of hematopoietic stem cells in vivo","volume":"116","author":"Lu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2019.11.016_bib0530","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.stem.2017.07.004","article-title":"Long-term engraftment of primary bone marrow stromal cells repairs niche damage and improves hematopoietic stem cell transplantation","volume":"21","author":"Abbuehl","year":"2017","journal-title":"Cell. Stem Cell"},{"key":"10.1016\/j.drudis.2019.11.016_bib0535","first-page":"13","article-title":"The regulation of hemopoietic cell development by the stromal cell environment and diffusible regulatory molecules","volume":"148","author":"Dexter","year":"1984","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.drudis.2019.11.016_bib0540","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3109\/10428190109097705","article-title":"Bone marrow stromal damage after chemo\/radiotherapy: occurrence, consequences and possibilities of treatment","volume":"42","author":"Banfi","year":"2001","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.drudis.2019.11.016_bib0545","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1084\/jem.147.5.1526","article-title":"Loss of proliferative capacity in immunohemopoietic stem cells caused by serial transplantation rather than aging","volume":"147","author":"Harrison","year":"1978","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0550","first-page":"101","article-title":"Long-term bone marrow damage in experimental systems and in patients after radiation or chemotherapy","volume":"5","author":"Testa","year":"1985","journal-title":"Anticancer Res."},{"key":"10.1016\/j.drudis.2019.11.016_bib0555","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bbmt.2018.06.021","article-title":"Dysfunctional bone marrow mesenchymal stem cells in patients with poor graft function after allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Song","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.drudis.2019.11.016_bib0560","first-page":"135","article-title":"Bone marrow regeneration after local injury: a review","volume":"3","author":"Patt","year":"1975","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0565","first-page":"610","article-title":"Residual marrow damage following therapy with cyclophosphamide","volume":"8","author":"Fried","year":"1980","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0570","first-page":"884","article-title":"Radiation damage to femoral hemopoietic stroma measured by implant regeneration and quantitation of fibroblastic progenitors","volume":"11","author":"Piersma","year":"1983","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0575","first-page":"1101","article-title":"Toxic effects on the hematopoietic microenvironment","volume":"19","author":"Greenberger","year":"1991","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0580","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.drudis.2019.11.016_bib0585","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.bmt.1704400","article-title":"Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation","volume":"33","author":"Maitra","year":"2004","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.drudis.2019.11.016_bib0590","first-page":"207","article-title":"Bone marrow stromal function from patients after bone marrow transplantation","volume":"15","author":"O\u2019Flaherty","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.drudis.2019.11.016_bib0595","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0301-472X(01)00744-5","article-title":"Basic fibroblast growth factor corrects proliferative derangement of bone marrow stroma and CD34(1) population following allogeneic stem cell transplantation","volume":"29","author":"Novitzky","year":"2001","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0600","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0301-472X(99)00076-4","article-title":"Stromal damage as consequence of high-dose chemo\/radiotherapy in bone marrow transplant recipients","volume":"27","author":"Galotto","year":"1999","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0605","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bmt.1701053","article-title":"Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients","volume":"21","author":"Soligo","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.drudis.2019.11.016_bib0610","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijrobp.2006.03.062","article-title":"The sensitivity of human mesenchymal stem cells to ionizing radiation","volume":"66","author":"Chen","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.drudis.2019.11.016_bib0615","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1634\/stemcells.2006-0108","article-title":"Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: evidence of resistance to apoptosis induction","volume":"24","author":"Mueller","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.drudis.2019.11.016_bib0620","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2141.2004.05200.x","article-title":"Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents","volume":"127","author":"Li","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0625","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00007890-198508000-00018","article-title":"Recovery of hemopoietic stromal progenitor cells after lethal total-body irradiation and bone marrow transplantation in mice","volume":"40","author":"Piersma","year":"1985","journal-title":"Transplantation"},{"key":"10.1016\/j.drudis.2019.11.016_bib0630","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1084\/jem.20091046","article-title":"Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow","volume":"206","author":"Morikawa","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0635","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.leu.2402763","article-title":"Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture","volume":"17","author":"Rombouts","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.drudis.2019.11.016_bib0640","first-page":"255","article-title":"Response of the preosteoblast and stem cell of rat bone marrow to a lethal dose of x-irradiation or cyclophosphamide","volume":"4","author":"Amsel","year":"1971","journal-title":"Cell Tissue Kinet."},{"key":"10.1016\/j.drudis.2019.11.016_bib0645","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/blood-2004-11-4422","article-title":"Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells","volume":"106","author":"Nilsson","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0650","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nature02041","article-title":"Identification of the haematopoietic stem cell niche and control of the niche size","volume":"425","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib0655","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1084\/jem.20041992","article-title":"Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size","volume":"201","author":"Stier","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0660","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/bloodadvances.2017008730","article-title":"Identification of a murine CD45(-)F4\/80(lo) HSC-derived marrow endosteal cell associated with donor stem cell engraftment","volume":"1","author":"Overholt","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.drudis.2019.11.016_bib0665","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1182\/blood-2012-10-463414","article-title":"Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning","volume":"121","author":"Olson","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0670","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/eji.200737553","article-title":"EMR1, the human homolog of F4\/80, is an eosinophil-specific receptor","volume":"37","author":"Hamann","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0675","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood-2005-04-1418","article-title":"Total body irradiation selectively induces murine hematopoietic stem cell senescence","volume":"107","author":"Wang","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0680","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor","volume":"6","author":"Coppe","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0685","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1074\/jbc.M109.058628","article-title":"Ionizing radiation induces cellular senescence of articular chondrocytes via negative regulation of SIRT1 by p38 kinase","volume":"285","author":"Hong","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2019.11.016_bib0690","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi","volume":"436","author":"Michaloglou","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib0695","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/436642a","article-title":"Tumour biology: senescence in premalignant tumours","volume":"436","author":"Collado","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib0700","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2011-06-361626","article-title":"Ionizing radiation-induced expression of INK4a\/ARF in murine bone marrow-derived stromal cell populations interferes with bone marrow homeostasis","volume":"119","author":"Carbonneau","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0705","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.4161\/cc.10.21.17972","article-title":"Activation of DNA damage response pathways in human mesenchymal stem cells exposed to cisplatin or gamma-irradiation","volume":"10","author":"Prendergast","year":"2011","journal-title":"Cell. Cycle"},{"key":"10.1016\/j.drudis.2019.11.016_bib0710","doi-asserted-by":"crossref","first-page":"8200","DOI":"10.1158\/0008-5472.CAN-09-1976","article-title":"Protein kinase CK2 regulates cytoskeletal reorganization during ionizing radiation-induced senescence of human mesenchymal stem cells","volume":"69","author":"Wang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2019.11.016_bib0715","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0092-8674(00)81400-2","article-title":"The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2\u2019s inhibition of p53","volume":"92","author":"Pomerantz","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2019.11.016_bib0720","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1073\/pnas.91.21.9926","article-title":"Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2\/AP1 repeat of the beta-globin locus control region","volume":"91","author":"Moi","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2019.11.016_bib0725","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1038\/sj.onc.1205905","article-title":"Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2","volume":"21","author":"Sekhar","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2019.11.016_bib0730","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/ncb2699","article-title":"Nrf2 regulates haematopoietic stem cell function","volume":"15","author":"Tsai","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0735","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.freeradbiomed.2012.10.536","article-title":"Loss of Nrf2 accelerates ionizing radiation-induced bone loss by upregulating RANKL","volume":"53","author":"Rana","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0740","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1667\/RR15059.1","article-title":"The role of Nrf2 in the response to normal tissue radiation injury","volume":"10","author":"Cameron","year":"2018","journal-title":"Radiat. Res."},{"key":"10.1016\/j.drudis.2019.11.016_bib0745","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/382635a0","article-title":"Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF\/SDF-1","volume":"382","author":"Nagasawa","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib0750","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MOH.0b013e3282f29012","article-title":"Chemokines in hematopoiesis","volume":"15","author":"Broxmeyer","year":"2008","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0755","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.drudis.2019.11.016_bib0760","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.20041385","article-title":"Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist","volume":"201","author":"Broxmeyer","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0765","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/blood-2010-01-266833","article-title":"Loss of Cxcl12\/Sdf-1 in adult mice decreases the quiescent state of hematopoietic stem\/progenitor cells and alters the pattern of hematopoietic regeneration after myelosuppression","volume":"117","author":"Tzeng","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0770","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1172\/JCI10329","article-title":"Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function","volume":"106","author":"Ponomaryov","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2019.11.016_bib0775","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cell.2005.10.041","article-title":"Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow","volume":"124","author":"Katayama","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2019.11.016_bib0780","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1182\/blood.V92.12.4641","article-title":"Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche","volume":"92","author":"Gupta","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0785","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc1391","article-title":"Hyaluronan: from extracellular glue to pericellular cue","volume":"4","author":"Toole","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.drudis.2019.11.016_bib0790","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/B978-0-12-800092-2.00006-X","article-title":"Hyaluronan in the healthy and malignant hematopoietic microenvironment","volume":"123","author":"Khaldoyanidi","year":"2014","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.drudis.2019.11.016_bib0795","first-page":"7","article-title":"Is hyaluronic acid the \u2018organizer\u2019 of the extracellular matrix in marrow stroma?","volume":"21","author":"Minguell","year":"1993","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0800","first-page":"126","article-title":"Hyaluronic acid regulates the function and distribution of sulfated glycosaminoglycans in bone marrow stromal cultures","volume":"21","author":"Siczkowski","year":"1993","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0805","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.matbio.2007.04.006","article-title":"Reduced supportive capacity of bone marrow stroma upon chemotherapy is mediated via changes in glycosaminoglycan profile","volume":"26","author":"Zweegman","year":"2007","journal-title":"Matrix Biol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0810","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/bmt.2010.87","article-title":"Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation","volume":"46","author":"Bernardo","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.drudis.2019.11.016_bib0815","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2007-04-087056","article-title":"Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation","volume":"110","author":"Ball","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0820","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2019.11.016_bib0825","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/bjh.12545","article-title":"Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease","volume":"163","author":"Ball","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0830","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bbmt.2008.03.012","article-title":"Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease","volume":"15","author":"Kebriaei","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.drudis.2019.11.016_bib0835","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/leu.2011.384","article-title":"Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring","volume":"26","author":"Dander","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.drudis.2019.11.016_bib0840","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2013.11.033","article-title":"Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients","volume":"20","author":"Introna","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1 Suppl","key":"10.1016\/j.drudis.2019.11.016_bib0845","first-page":"S3","article-title":"Clinical grade production of mesenchymal stem cells","volume":"18","author":"Sensebe","year":"2008","journal-title":"Biomed. Mater. Eng."},{"key":"10.1016\/j.drudis.2019.11.016_bib0850","first-page":"72","article-title":"Translational research on advanced therapies","volume":"47","author":"Belardelli","year":"2011","journal-title":"Ann. Ist. Super. Sanita"},{"key":"10.1016\/j.drudis.2019.11.016_bib0855","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/ten.teb.2009.0825","article-title":"Different facets of aging in human mesenchymal stem cells","volume":"16","author":"Wagner","year":"2010","journal-title":"Tissue Eng. B. Rev."},{"key":"10.1016\/j.drudis.2019.11.016_bib0860","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1080\/14653240500363216","article-title":"Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture","volume":"7","author":"Wang","year":"2005","journal-title":"Cytotherapy"},{"key":"10.1016\/j.drudis.2019.11.016_bib0865","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/jcb.23100","article-title":"Cell-cycle phases and genetic profile of bone marrow-derived mesenchymal stromal cells expanded in vitro from healthy donors","volume":"112","author":"Achille","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.drudis.2019.11.016_bib0870","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2019.11.016_bib0875","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/JCO.2000.18.2.307","article-title":"Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy","volume":"18","author":"Koc","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0880","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","article-title":"Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients","volume":"11","author":"Lazarus","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.drudis.2019.11.016_bib0885","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1182\/blood-2003-05-1601","article-title":"Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation","volume":"103","author":"Kim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0890","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/bmt.2008.348","article-title":"Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial","volume":"43","author":"Macmillan","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.drudis.2019.11.016_bib0895","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/14653240902807018","article-title":"Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults","volume":"11","author":"Gonzalo-Daganzo","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.drudis.2019.11.016_bib0900","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/bmt.2011.102","article-title":"Mesenchymal stromal cells: a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation?","volume":"47","author":"Bernardo","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.drudis.2019.11.016_bib0905","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1182\/blood.V95.11.3620","article-title":"Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation","volume":"95","author":"Almeida-Porada","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0910","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0301-472X(02)00820-2","article-title":"Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(1) cells in NOD\/SCID mice","volume":"30","author":"Noort","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0915","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/stem.157","article-title":"Cotransplantation of placental mesenchymal stromal cells enhances single and double cord blood engraftment in nonobese diabetic\/severe combined immune deficient mice","volume":"27","author":"Hiwase","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.drudis.2019.11.016_bib0920","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0301-472X(00)00635-4","article-title":"Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion","volume":"29","author":"Devine","year":"2001","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0925","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood-2004-02-0526","article-title":"A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow","volume":"104","author":"Wynn","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib0930","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/298222a0","article-title":"Is the marrow stroma transplantable?","volume":"298","author":"Dexter","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib0935","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/298280a0","article-title":"Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man","volume":"298","author":"Keating","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib0940","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2141.1991.tb08041.x","article-title":"Recipient origin of bone marrow-derived fibroblastic stromal cells during all periods following bone marrow transplantation in humans","volume":"79","author":"Agematsu","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0945","first-page":"255","article-title":"Host origin of bone marrow fibroblasts following allogeneic bone marrow transplantation for chronic myeloid leukemia","volume":"10","author":"Santucci","year":"1992","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.drudis.2019.11.016_bib0950","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0301-472X(99)00101-0","article-title":"Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases","volume":"27","author":"Koc","year":"1999","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0955","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/6529","article-title":"Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta","volume":"5","author":"Horwitz","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0960","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7","article-title":"Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells","volume":"176","author":"Majumdar","year":"1998","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.drudis.2019.11.016_bib0965","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1084\/jem.189.4.729","article-title":"Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice","volume":"189","author":"Nilsson","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0970","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/MPA.0b013e318215cdce","article-title":"Mesenchymal stem cells facilitate mixed hematopoietic chimerism induction and prevent onset of diabetes in nonobese diabetic mice","volume":"40","author":"Asari","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.drudis.2019.11.016_bib0975","first-page":"4479","article-title":"Stem cell transplantation for the treatment of patients with type 1 diabetes mellitus: a meta-analysis","volume":"16","author":"Gan","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib0980","unstructured":"MSC and cyclophosphamide for acute graft-versus-host disease (aGVHD) prophylaxis."},{"key":"10.1016\/j.drudis.2019.11.016_bib0985","unstructured":"Intra-osseous co-transplant of UCB and hMSC."},{"key":"10.1016\/j.drudis.2019.11.016_bib0990","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-bioeng-070909-105309","article-title":"Mesenchymal stem cells as therapeutics","volume":"12","author":"Parekkadan","year":"2010","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.drudis.2019.11.016_bib0995","unstructured":"Safety and efficacy study of adult human mesenchymal stem cells to treat acute GVHD."},{"key":"10.1016\/j.drudis.2019.11.016_bib1000","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","article-title":"Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo","volume":"30","author":"Bartholomew","year":"2002","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib1005","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2019.11.016_bib1010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1465-3249(05)70787-8","article-title":"Mesenchymal stem cells: progress toward promise","volume":"7","author":"Le Blanc","year":"2005","journal-title":"Cytotherapy"},{"key":"10.1016\/j.drudis.2019.11.016_bib1015","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/968213","article-title":"Multipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-host disease-a phase II study","volume":"2012","author":"Kuzmina","year":"2012","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.drudis.2019.11.016_bib1020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature03100","article-title":"Tissue repair and stem cell renewal in carcinogenesis","volume":"432","author":"Beachy","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib1025","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature09262","article-title":"Mesenchymal and haematopoietic stem cells form a unique bone marrow niche","volume":"466","author":"Mendez-Ferrer","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib1030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nri.2017.53","article-title":"Adult haematopoietic stem cell niches","volume":"17","author":"Crane","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.drudis.2019.11.016_bib1035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib1040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1392.021","article-title":"Dormant and self-renewing hematopoietic stem cells and their niches","volume":"110","author":"Wilson","year":"2007","journal-title":"Ann. N. Y. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2019.11.016_bib1045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.stem.2010.01.011","article-title":"Stem cells and the niche: a dynamic duo","volume":"6","author":"Voog","year":"2010","journal-title":"Cell. Stem Cell"},{"key":"10.1016\/j.drudis.2019.11.016_bib1050","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1126\/science.1064081","article-title":"Physiological migration of hematopoietic stem and progenitor cells","volume":"294","author":"Wright","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.drudis.2019.11.016_bib1055","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2005.05.026","article-title":"SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells","volume":"121","author":"Kiel","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2019.11.016_bib1060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.ctdb.2016.01.009","article-title":"Hematopoietic stem cell and its bone marrow niche","volume":"118","author":"Yu","year":"2016","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.drudis.2019.11.016_bib1065","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar2116","article-title":"Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation","volume":"9","author":"Kolf","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.drudis.2019.11.016_bib1070","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1182\/blood-2016-09-740563","article-title":"Numerous niches for hematopoietic stem cells remain empty during homeostasis","volume":"129","author":"Shimoto","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib1075","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201745702","article-title":"Functional compensation between hematopoietic stem cell clones in vivo","volume":"19","author":"Nguyen","year":"2018","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drudis.2019.11.016_bib1080","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.1149726","article-title":"Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches","volume":"318","author":"Czechowicz","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.drudis.2019.11.016_bib1085","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1084\/jem.20090778","article-title":"Niche recycling through division-independent egress of hematopoietic stem cells","volume":"206","author":"Bhattacharya","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2019.11.016_bib1090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.stem.2015.02.019","article-title":"Mesenchymal cell contributions to the stem cell niche","volume":"16","author":"Kfoury","year":"2015","journal-title":"Cell. Stem Cell"},{"key":"10.1016\/j.drudis.2019.11.016_bib1095","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nature12612","article-title":"Arteriolar niches maintain haematopoietic stem cell quiescence","volume":"502","author":"Kunisaki","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib1100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature11885","article-title":"Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches","volume":"495","author":"Ding","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.drudis.2019.11.016_bib1105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3324\/haematol.2009.017038","article-title":"Stem cell transplantation for autoimmune diseases","volume":"95","author":"Hugle","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.drudis.2019.11.016_bib1110","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.celrep.2016.04.061","article-title":"Transplantation dose alters the differentiation program of hematopoietic stem cells","volume":"15","author":"Brewer","year":"2016","journal-title":"Cell. Rep."},{"key":"10.1016\/j.drudis.2019.11.016_bib1115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.stem.2007.08.016","article-title":"Limiting factors in murine hematopoietic stem cell assays","volume":"1","author":"Purton","year":"2007","journal-title":"Cell. Stem Cell"},{"key":"10.1016\/j.drudis.2019.11.016_bib1120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00007890-197108000-00001","article-title":"Osteogenic precursor cells of bone marrow in radiation chimeras","volume":"12","author":"Friedenstein","year":"1971","journal-title":"Transplantation"},{"key":"10.1016\/j.drudis.2019.11.016_bib1125","first-page":"770","article-title":"Role of bone marrow stroma in hemopoietic stem cell regulation","volume":"8","author":"Chertkov","year":"1980","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.drudis.2019.11.016_bib1130","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood.V96.6.2307","article-title":"Implantation of bone marrow beneath the kidney capsule results in transfer not only of functional stroma but also of hematopoietic repopulating cells","volume":"96","author":"Varas","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2019.11.016_bib1135","first-page":"2972","article-title":"HLA genotyping in the international Type 1 Diabetes Genetics Consortium","volume":"59","author":"Mychaleckyj","year":"2010","journal-title":"Clin. Trials"},{"key":"10.1016\/j.drudis.2019.11.016_bib1140","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11892-011-0223-x","article-title":"Genetics of the HLA region in the prediction of type 1 diabetes","volume":"11","author":"Noble","year":"2011","journal-title":"Curr. Diab Rep."},{"key":"10.1016\/j.drudis.2019.11.016_bib1145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3727\/096020198389843","article-title":"Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes","volume":"11","author":"Zorina","year":"2002","journal-title":"Cell Transplant."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644619304581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644619304581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:45:45Z","timestamp":1761223545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644619304581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":229,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1359644619304581"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2019.11.016","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-based immunomodulatory therapy approaches for type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2019.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}